SCHEMBL30155046

SCHEMBL30155046

c1ccc(-c2c3c(c(-c4ccccc4)c4ccccc24)-c2cccc4cccc-3c24)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
HSD17B10 Q99714 5/20 0.50
MAPK1 P28482 5/20 0.50
TSHR P16473 4/20 0.50
L3MBTL1 Q9Y468 4/20 0.50
ATM Q13315 2/20 0.50
HPGD P15428 5/20 0.45
CASP1 P29466 3/20 0.45
CASP7 P55210 2/20 0.45
TP53 P04637 2/20 0.45
HIF1A Q16665 2/20 0.45
ENPP1 P22413 2/20 0.44
CYP1A2 P05177 1/20 0.43
THRB P10828 1/20 0.43
CES1 P23141 2/20 0.41
CES2 O00748 1/20 0.41
BCHE P06276 1/20 0.41
MCL1 Q07820 1/20 0.41
CYP3A4 P08684 1/20 0.41
PABPC1 P11940 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503284 1.00 ALDH1A1 (0.50) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL13911239 0.89 TNF (0.47) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL13085133 0.89 ALDH1A1 (0.45) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL728324 0.89 ALDH1A1 (0.56) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL13911242 0.87 ALDH1A1 (0.38) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL3683071 0.86 ALDH1A1 (0.45) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL13170639 0.85 SLC22A12 (0.40) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL13080597 0.85 CDK4 (0.38) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL14226897 0.85 ENPP1 (0.48) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1
SCHEMBL5077287 0.85 ALDH1A1 (0.42) ALDH1A1HSD17B10MAPK1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252841-B1 ORGANIC LIGHT EMITTING DIODE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER NOVALED GMBH (DE) 2026-04-01 EP disclosed
US-12563963-B2 Electron injection layer for an organic light-emitting diode (OLED) NOVALED GMBH (DE) 2026-02-24 US disclosed
US-12161044-B2 Electron transport layer comprising a matrix compound mixture for an organic light-emitting diode (OLED) NOVALED GMBH (DE) 2024-12-03 US disclosed
US-11594687-B2 Organic electroluminescent device NOVALED GMBH (DE) 2023-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12563963-B2 Electron injection layer for an organic light-emitting diode (OLED) ICOSLG, OXA1L, OSBP2 ALDH1A1 1592/4885HSD17B10 386/4885MAPK1 412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.